Bill Higgins Email & Phone Number

• Work with top pharmaceutical companies in assessing implementation of product brand strategy, core selling and coaching skills with field sales and first line leadership.

Charlotte, North Carolina Area

Specialty sales of injectables, advanced cardiovascular testing.

Charlotte/Greensboro/Winston-Salem

• Hyperlipidemia, COPD, asthma, diabetes, thrombotic CV events.
• In the first half of 2015 before the sales force restructuring, led the region in NRx share growth for Symbicort, attaining +.25% growth vs. -.46% decline for the region.
• In 2013 my district ranked first in the region for Symbicort NRx YTD market share change and 34th nationally out of 178 districts.
• In 2014 Crestor goal attainment and Performance Index exceeded 100% and above national performance.
• Proactively researched and developed an educational web-ex training program regarding Patient Centered Medical Homes (PCMH’s) for the region’s sales representatives.

Eastern North Carolina

• Schizophrenia, Bipolar Disorder, Major Depressive Disorder, pain
• In 2010 ranked 16th out of 66 districts in market share change for Seroquel XR.
• Successfully launched Vimovo in late 2010, ranking 22nd out of 66 teams in June ‘11 YTD market share and 8th in new Rx market share growth Q2 ’11 vs Q1 ’11 reflecting strong growth

Mid-Atlantic, Southeast

• Local/general surgical anesthesia, gram-positive/negative infections, COPD, asthma, gastrointestinal, hyperlipidemia, hypertension, schizophrenia, Bi-polar disorders. Integrated Delivery Networks and major teaching.
• Consistently ranking in the top 20% for yearly sales performance, meeting or exceeding overall job performance expectations.
• Ranked first in the region for Merrem performance, ’07 - 142% of goal, 54% MS, 62% CY vs PY volume increase. In ’08 grew sales 27% YTD, eclipsed $1 million in sales YTD.
• Organized and led region DSM team regarding a collaborative initiative at the VA Hospital Mental Health units.
• Launching Seroquel XR in 2008, the district outperformed the region and nation in both NRx market share growth as well as overall NRx market share, ranking first the region. Secured formulary priority with South.

Wilmington, DE

Developed and implemented marketing plans for Naropin, a long acting local anesthetic and EMLA cream, a topical anesthetic in a rotational assignment. Managed a $4.5 million budget, conducting marketing research and developing marketing plans to drive sales for products not being sold directly by sales representatives in the field. Maintained.